{"id":"W2110534364","doi":"10.1056/nejmoa1014618","title":"Abiraterone and Increased Survival in Metastatic Prostate Cancer","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4394,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Université de Montréal; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Abiraterone acetate; Medicine; Prednisone; Prostate cancer; Hazard ratio; Internal medicine; Urology; Clinical endpoint; Placebo; Antiandrogen; Interim analysis; Adverse effect; Androgen deprivation therapy; Oncology; Randomized controlled trial; Cancer; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008157716,0.0001726315,0.0003943662,0.0002298106,0.0001497698,0.0001731026,0.0001376635,0.000203286,0.001382564],"category_scores_gemma":[0.001770668,0.00006553665,0.0003546111,0.0002879853,0.0002165936,0.00009763614,0.0001637706,0.0004146937,0.00009882914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003918238,"about_ca_system_score_gemma":0.0004330633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006913303,"about_ca_topic_score_gemma":0.001721078,"domain_scores_codex":[0.9996803,0.0001401255,0.00002390918,0.00002755675,0.0000913339,0.00003682531],"domain_scores_gemma":[0.9990777,0.0003340542,0.0003094096,0.0000295191,0.00005134366,0.0001979674],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1578473,0.001974481,0.5222138,0.001618738,0.001522027,0.001390456,0.0004477324,0.004682156,0.03599133,0.0005580482,0.002206254,0.2695478],"study_design_scores_gemma":[0.008939938,0.05288365,0.9180709,0.0001963157,0.001091841,0.003765853,0.0001283446,0.00201923,0.004424031,0.001130878,0.007318122,0.00003092409],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902721,0.008514582,0.0001347075,0.0001675005,0.00003566057,0.00002301407,0.0001014359,0.00001113014,0.0007399076],"genre_scores_gemma":[0.9987161,0.0009181029,0.00007958653,0.00004458516,0.0000319542,0.000008842627,0.00006373582,8.588623e-7,0.0001363724],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001382564,"threshold_uncertainty_score":0.004625142,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06641357971523264,"score_gpt":0.3362644191071107,"score_spread":0.269850839391878,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}